Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
Recruiting now
Conditions studied: Respiratory Tract Infections (RTI), Influenza -Like Illness, Influenza, COVID - 19, RSV Infections, Rhinovirus Infection, Metapneumovirus Infection
In brief
Every year in the fall and winter, numerous respiratory viruses (such as influenza viruses, SARS-CoV-2 (COVID-19), RSV, rhinovirus, and metapneumovirus) circulate in mainland France, causing acute respiratory infections (ARIs). These viruses can cause epidemics of varying severity, requiring close monitoring to determine their circulation levels and adapt public health measures accordingly. In France, ARI surveillance relies on two networks: the Sentinelles network in primary care and the RENAL network in hospitals. The Sentinelles surveillance is conducted in collaboration with Santé publique France, the National Reference Center for Respiratory Infection Viruses (Institut Pasteur and Hospices Civils de Lyon), and the University of Corsica. As part of the virological surveillance of ARIs, Sentinelles physicians are asked to collect nasopharyngeal swabs or saliva samples from a sample of patients presenting with an ARI during their clinic visits. This surveillance makes it possible to identify respiratory viruses circulating in primary care (general practice and pediatrics), to describe confirmed cases for each of the circulating viruses, and to estimate the impact of each on general practice. This surveillance also allows for the evaluation of the effectiveness of vaccines against influenza and COVID-19.
Key facts
- Study ID
- NCT07599449
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
- People needed
- 25000
- Starts
- 2026-05-14
- Expected to finish
- 2031-05-14
- Last updated by the study team
- 2026-08-03
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- be seen by a general practitioner or pediatrician participating in the Sentinelles surveillance program;
- between week 40 (late September-early October) and week 15 (mid-April) of each year
- have an acute respiratory infection (ARI) as defined below: Sudden onset of fever (or feeling of fever) and respiratory symptoms
- have given oral consent to participate in this monitoring or, in the case of minors, oral consent given by the child's legal guardian(s) present at the consultation
You may not qualify if…
- a person who is subject to a court-ordered protective measure;
- a person who is under guardianship or conservatorship, unless accompanied by their legal guardian or unless the legal guardian objects to their participation;
- a person who is not in a condition to receive information or give consent.
Where it is running
- IPLESP - UMR S 1136, N° BC 2908, Faculté de médecine Sorbonne Université, site Saint Antoine, 27 rue Chaligny — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.